Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2010 - 2025)
Lineage Cell Therapeutics (LCTX) posted quarterly Other Operating Expenses of $66000.0 for Q4 2025, down 57.14% year-over-year from $154000.0 in Q4 2024, and up 1220.0% quarter-over-quarter from $5000.0 in Q3 2025.
Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2010 - 2025) Analysis & Trends
Lineage Cell Therapeutics' Other Operating Expenses history runs 11 years deep, the most recent figure standing at $66000.0 for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 57.14% year-over-year to $66000.0; the TTM figure through Mar 2026 stood at $15.0 million (up 5396.32% YoY), while the FY2025 annual figure was $15.0 million, up 4386.83% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $66000.0, up from $5000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $14.9 million in Q2 2025, with the low at $5000.0 in Q3 2025.
- The 3-year median for Other Operating Expenses is $98000.0 (2024), against an average of $1.4 million.
- Peak annual rise in Other Operating Expenses reached 33715.91% in 2025, while the deepest fall reached 86.84% in 2025.
- Lineage Cell Therapeutics' Other Operating Expenses stood at $169000.0 in 2023, then declined by 8.88% to $154000.0 in 2024, then sank by 57.14% to $66000.0 in 2025.
- Business Quant data shows LCTX's Other Operating Expenses at $66000.0 in Q4 2025, $5000.0 in Q3 2025, and $14.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2018 | -108,000.00 |
| Mar 31, 2018 | 800,000.00 |
| Jun 30, 2017 | 1.75 Mn |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2014 | -217.00 |
| Sep 30, 2014 | -133.00 |
| Mar 31, 2014 | -8,576.00 |
| Sep 30, 2013 | 5,830.00 |
| Jun 30, 2013 | 800.00 |